Berestjuk, I., Lecacheur, M., Carminati, A., Diazzi, S., Rovera, C., Prod’homme, V., . . . Tartare‐Deckert, S. Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma. Springer Nature.
Chicago Style (17th ed.) CitationBerestjuk, Ilona, et al. Targeting Discoidin Domain Receptors DDR1 and DDR2 Overcomes Matrix‐mediated Tumor Cell Adaptation and Tolerance to BRAF‐targeted Therapy in Melanoma. Springer Nature.
MLA (9th ed.) CitationBerestjuk, Ilona, et al. Targeting Discoidin Domain Receptors DDR1 and DDR2 Overcomes Matrix‐mediated Tumor Cell Adaptation and Tolerance to BRAF‐targeted Therapy in Melanoma. Springer Nature.
Warning: These citations may not always be 100% accurate.